Preview

Неврология, нейропсихиатрия, психосоматика

Расширенный поиск

Когнитивные и некогнитивные нейропсихические расстройства при деменции и методы их коррекции

https://doi.org/10.14412/2074-2711-2017-2-65-70

Полный текст:

Аннотация

Деменция – этиологически гетерогенный синдром, традиционная оценка тяжести которого основана на степени снижения познавательной деятельности и нарушения функциональных способностей. Кроме когнитивных нарушений (КН), клиническую картину деменции формируют некогнитивные нейропсихические расстройства, распространенность которых достигает 50–100%. Некогнитивные нарушения в значительной мере связаны с тяжестью, течением и худшим исходом деменции. Нейропсихические некогнитивные расстройства характеризуются различными симптомами, что связано с гетерогенностью деменции. Основные проявления включают в себя агрессию, ажитацию, блуждание, накопительство, сексуальную расторможенность, апатию, депрессию и тревогу. В статье рассмотрены основные кластеры нейропсихических расстройств, их клинические проявления. Приведены данные о комплексном лечении КН и некогнитивных расстройств при деменции. 

Об авторе

Е. Г. Менделевич
ФГБОУ ВО «Казанский государственный медицинский университет» Минздрава России, Казань
Россия

Кафедра неврологии и реабилитации 

420012, Казань, ул. Бутлерова, 49



Список литературы

1. Christensen K, Doblhammer G, Rau R, et al. Ageing populations: the challenges ahead. Lancet. 2009 Oct 3;374(9696):1196-208. doi: 10.1016/S0140-6736(09)61460-4.

2. Яхно НН, Захаров ВВ, Локшина АБ и др. Деменции: руководство для врачей. 3-е изд. Москва: МЕДпреcс-информ; 2011. 272 с. [Yakhno NN, Zakharov VV, Lokshina AB, et al. Dementsii: rukovodstvo dlya vrachei. [Dementia: a guide for physicians]. 3rd edition. Moscow: MEDprecs-inform; 2011. 272 p.]

3. Simpson JR. DSM-5 and Neurocognitive Disorders. J Am Acad Psychiatry Law. 2014; 42(2):159-64.

4. Diagnostic and statistical manual of mental dis￾eases. V ed. (DSM-V). London: American Psychiatric Association; 2013.

5. Santos C, Snyder P, Wu W, et al. Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis. Alzheimers Dement (Amst). 2017 Feb 9;7:69-87. doi: 10.1016/j.dadm. 2017.01.005. eCollection 2017.

6. Au R, Piers R, Lancashire L. Back to the future: Alzheimer’s disease heterogeneity revisited. Alzheimers Dement (Amst). 2015 Sep; 1(3):368-370.

7. Hersch E, Falzgraf S. Management of the behavioral and psychological symptoms of demen￾tia. Clin Interv Aging. 2007;2(4):611-21.

8. Emanuel J, Lopez O, Houck P, et al. Trajectory of cognitive decline as a predictor of psychosis in early Alzheimer disease in the cardiovascular health study. Am J Geriatr Psychiatry. 2011 Feb;19(2): 160-8. doi: 10.1097/JGP.0b013e3181e446c8.

9. Alzheimer A. Über einen eigenartigen schweren Er Krankungsprozeb der Hirnrinde. Neurologisches Centralblatt. 1906;(23):1129–36.

10. Neil W, Bowie P. Carer burden in dementiaassessing the impact of behavioural and psychologi￾cal symptoms via self-report questionnaire. Int J Geriatr Psychiatry. 2008 Jan;23(1):60-4.

11. Lyketsos C, Sheppard M, Steinberg M, et al. Neuropsychiatric disturbance in Alzheimer’s dis￾ease cluster into three groups: The Cache Countty Study. Int J Geriatr Psychiatry. 2001 Nov;16(11): 1043-53.

12. Lyketsos C, Lopez O, Jones B, et al. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment, results from the cardio￾vascular health study. JAMA. 2002 Sep 25;288(12): 1475-83.

13. Tun S, Murman D, Long H, et al. Predictive validity of neuropsychiatric subgroups on nursing home placement and survival in patients with Alzheimer disease. Am J Geriatr Psychiatry. 2007 Apr;15(4):314-27.

14. Benoit M, Staccini P, Brocker P, et al. Behavioral and psychologic symptoms in Alzheimer’s disease: results of the REAL. FR study. Rev Med Interne. 2003 Oct;24 Suppl 3: 319s-324s.

15. Monastero R, Mangialasche F, Camarda C, et al. A systematic review of neuropsychiatric symptoms in mild cognitive impairment. J Alzheimers Dis. 2009;18(1):11-30. doi: 10.3233/JAD-2009-1120.

16. Lobo A, Lopez-Anton R, De-la-Camara C, et al. Non-Cognitive Psychopathological Symptoms Associated with Incident Mild Cognitive Impairment and Dementia, Alzheimer's Type. Neurotox Res. 2008 Oct; 14(2-3):263-72. doi: 10.1007/BF03033815.

17. Masters M, Morris J, Roe C. «Noncognitive» symptoms of early Alzheimer disease. A longitudi￾nal analysis. Neurology. 2015 Feb 10;84(6):617-22.

18. Rosenberg P, Mielke M, Appleby B, et al. Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction. Int J Geriatr Psychiatry. 2011 Apr;26(4):364-72. doi: 10.1002/gps.2535. Epub 2010 Sep 15.

19. Teng E, Lu P, Cummings J. Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer's disease. Dement Geriatr Cogn Disord. 2007;24(4):253-9. Epub 2007 Aug 14.

20. Ismail Z, Nguyen M, Fischer C, et al. Neurobiology of delusions in Alzheimer’s disease. Curr Psychiatry Rep. 2011 Jun;13(3): 211-8. doi: 10.1007/s11920-011-0195-1.

21. Finkel S, Costa вe Silva J, Cohen G, et al. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr. 1996;8 Suppl 3:497-500.

22. Pruszynski J. Non-cognitive symptoms of dementia. Postepy Nauk Medycznych. 2015;(7): 477-81.

23. Ford A. Neuropsychiatric symptoms of dementia: are pharmacological treatments effective and safe? J Neurol Neurosurg Psychiatry. 2015 Jan; 86(1):101-9. doi: 10.1136/ jnnp-2014-308112. Epub 2014 May 29.

24. Vega U, Marinho V, Engelhardt E, et al. Neuropsychiatric symptoms in dementias: preliminary report of a prospective outpatient evaluation in Brazil. Arq Neuropsiquiatr. 2007 Jun; 65(2B): 498-502.

25. Cerejeira J, Lagarto L, Mukaetova-Ladinska E. Behavioral and Psychological Symptoms of Dementia. Front Neurol. 2012 May 7;3:73. doi: 10.3389/fneur.2012.00073. eCollection 2012.

26. Lam L, Leung T, Lui V, et al. Association between cognitive function, behavioral syndromes and two-year clinical outcome in Chinese subjects with late-onset alzheimer’s disease. Int Psychogeriatr. 2006 Sep;18(3): 517-26. Epub 2006 Feb 8.

27. Lytetsos C, Lee H. Diagnosis and treatment of depression in Alzheimer’s disease: A practical update for the clinician. Dement Geriatr Cogn Disord. 2004;17(1-2):55-64. Epub 2003 Oct 15.

28. Prado-Jean A, Couratier P, Druet-Cabanac M, et al. Specific psychologicaland behavioral symptoms of depression in patients with dementia. Int J Geriatr Psychiatry. 2010 Oct;25(10):1065-72. doi: 10.1002/gps.2468.

29. Deutsch L, Rovner B. Agitation and other noncognitive abnormalities in Alzheimer’s disease. Psychiatr Clin North Am. 1991 Jun;14(2): 341-51.

30. Boyle P, Malloy P. Treating apathy in Alzheimer’s disease. Dement Geriatr Cogn Disord. 2004;17(1-2):91-9. Epub 2003 Oct 15.

31. Lobo A, Saz P, Marcos G, et al. The prevalence of dementia and depression in the elderly community in a Southern European population: the Zaragoza study. Arch Gen Psychiatry. 1995 Jun; 52(6):497-506.

32. Ganguli M, Du Y, Dodge H, et al. Depressive symptoms and cognitive decline in late life: a prospective epidemiological study. Arch Gen Psychiatry. 2006 Feb;63(2):153-60.

33. Reul J, Chandramohan Y. Epigenetic mecha￾nisms in stress-related memory formation. Psychoneuroendocrinology. 2007 Aug;32 Suppl 1:S21-5. Epub 2007 Jul 17.

34. Korczyn AD, Halperin I. Depression and dementia. J Neurol Sci. 2009 Aug 15;283(1-2):139- 42. doi: 10.1016/j.jns.2009.02.346. Epub 2009 Apr 5.

35. Wilson R, Barnes L, Mendes de Leon C, et al. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology. 2002 Aug 13;59(3):364-70.

36. Kar N. Behavioral and psychological symptoms of dementia and their management. Indian J Psychiatry. 2009;51(1):77–86.

37. Jeste D, Finkel S. Psychosis of Alzheimer’s disease and related dementias: Diagnostic criteria for a distinct syndrome. Am J Geriatr Psychiatry. 2000 Winter;8(1):29-34.

38. Cohen-Mansfield J, Billing N. Agitated behaviors in the elderly: A concep-tual reviev. J Am Geriatr Soc. 1986 Oct;34(10):711-21.

39. Cohen-Mansfield J, Marx M, Dakheel-Ali M, et al. Can agitated behavior of nursing home residents with dementia be prevented with the use of standardized stimuli? J Am Geriatr Soc. 2010 Aug;58(8):1459-64. doi: 10.1111/j.1532-5415.2010. 02951.x. Epub 2010 Jun 23.

40. Rozzini L, Chilovi V, Conti M, et al. Neuropsychiatric symptoms in amnestic and non￾amnestic mild cognitive impairment. Dement Geriatr Cogn Disord. 2008;25(1):32-6. Epub 2007 Nov 19.

41. Lishman W. Organic Psychiatry: The Psychological Consequences of Cerebral Disorder. Oxford: Blackwell Scientific Publication; 1987. 745 p.

42. Cummings JL. The neuropsychiatric inventory: assessing psychopathology in dementia patients. Neurology. 1997 May;48(5 Suppl 6):S10-6.

43. Anor C, O'Connor S, Saund A, et al. Neuropsychiatric Symptoms in Alzheimer Disease, Vascular Dementia, and Mixed Dementia. Neurodegener Dis. 2017 Mar 1;17(4-5):127-134. doi: 10.1159/000455127. [Epub ahead of print].

44. Staekenborg S, Su T, van Straaten E, et al. Behavioural and psychological symptoms in vascular dementia; differences between small- and large￾vessel disease. J Neurol Neurosurg Psychiatry. 2010 May;81(5):547-51. doi: 10.1136/jnnp.2009.187500. Epub 2009 Dec 3.

45. Aalten P, de Vugt M, Jaspers N, et al. The course of neuropsychiatric symptoms in dementia. Part II: relationships among behavioural sub-syndromes and the influence of clinical variables. Int J Geriatr Psychiatry. 2005 Jun;20(6):531-6.

46. Devanand D, Jacobs D, Tang M, et al. The course of psychopathologic features in mild to moderate Alzheimer disease. Arch Gen Psychiatry. 1997 Mar;54(3):257-63.

47. Alexopoulos G. Depression in the elderly. Lancet. 2005 Jun 4-10;365(9475):1961-70.

48. Casanova M, Starkstein S, Jellinger K. Clinicopathological correlates of behavioral and psychological symptoms of dementia. Acta Neuropathol. 2011 Aug;122(2):117-35. doi: 10.1007/s00401-011-0821-3. Epub 2011 Apr 1.

49. O'Brien J, Holmes C, Jones M, et al. Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology. J Psychopharmacol. 2017 Feb;31(2):147-168. doi: 10.1177/0269881116680924. Epub 2017 Jan 20.

50. Гаврилова СИ. Мемантин в лечении болезни Альцгеймера: 20 лет клинического применения. Журнал неврологии и психиатрии им. С.С. Корсакова. 2016;116(6):10-8. [Gavrilova SI. Memantine in treatment of Alzheimer's disease: 20 years of clinical use. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2016;116(6):10-8. (In Russ.)].

51. McShane R, AreosaSastre A, Minakaran N. Memantine for dementia. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003154.

52. Deardorff W, Grossberg G. Pharmacotherapeutic strategies in the treatment of severe Alzheimer's disease. Expert Opin Pharmacother. 2016 Sep;17(13):1789-800. doi: 10.1080/14656566. 2016.1215431. Epub 2016 Jul 29.

53. Yabuki Y, Matsuo K, Hirano K, et al. Combined Memantine and Donepezil Treatment Improves Behavioral and Psychological Symptoms of Dementia-Like Behaviors in Olfactory Bulbectomized Mice. Pharmacology. 2017;99(3-4): 160-171. doi: 10.1159/000452839. Epub 2017 Jan 4.

54. Haussmann R, Donix M. Memantine as addon medication to acetylcholinesterase inhibitor therapy for Alzheimer dementia. Nervenarzt. 2017 Jan;88(1):40-45. doi: 10.1007/s00115-016-0237-3.

55. Desmidt T, Hommet C, Camus V. Pharmacological treatments of behavioral and psychological symptoms of dementia in Alzheimer's disease: role of acetylcholinesterase inhibitors and memantine. Geriatr Psychol Neuropsychiatr Vieil. 2016 Sep 1;14(3):300-6. doi: 10.1684/pnv.2016.0621.

56. Cumbo E, Ligori LD. Differential Effects of Сurrеnt Specific Treatments on Behavioral and Psychological Symptoms in Patients with Alzheimer's Disease: АI2-month, randomized, open-label trial. JоumаI of Alzheimer's Disease. 2014;39:417-85.

57. Li P, Quan W, Zhou Y. et al. Efficacy of memantine on neuropsychiatric symptoms associated with the severity of behavioral variant frontotemporal dementia: A six-month, open-label, self-controlled clinical trial. Exp Ther Med. 2016 Jul;12(1):492-498. Epub 2016 Apr 20.

58. Gauthier S, Cummings J, Ballard C, et al. Management of behavioral problems in Alzheimer’s disease. Int Psychogeriatr. 2010 May; 22(3):346-72. doi: 10.1017/S1041610209991505. Epub 2010 Jan 25.

59. Wang J, Yu J, Wang H, et al. Pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease: a systematic review and metaanalysis. J Neurol Neurosurg Psychiatry. 2015 Jan; 86(1):101-9. doi: 10.1136/jnnp-2014-308112. Epub 2014 May 29.

60. Miller LJ. The use of cognitive enhancers in behavioral disturbances of Alzheimer’s disease. Consult Pharm. 2007 Sep;22(9):754-62.


Для цитирования:


Менделевич Е.Г. Когнитивные и некогнитивные нейропсихические расстройства при деменции и методы их коррекции. Неврология, нейропсихиатрия, психосоматика. 2017;9(2):65-70. https://doi.org/10.14412/2074-2711-2017-2-65-70

For citation:


Mendelevich E.G. Cognitive and non-cognitive neuropsychiatric disorders in dementia and methods of their correction. Neurology, Neuropsychiatry, Psychosomatics. 2017;9(2):65-70. (In Russ.) https://doi.org/10.14412/2074-2711-2017-2-65-70

Просмотров: 204


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)